Regeneron Pharmaceuticals, Inc.
Multispecific Antigen-Binding Molecules for Cell Targeting and Uses Thereof
Last updated:
Abstract:
The present invention provides multispecific antigen-binding molecules that bind both a T-cell antigen (e.g., CD3) and a target antigen (e.g., a tumor associated antigen, a viral or bacterial antigen), and which include a single polypeptide chain that is multivalent (e.g., bivalent) with respect to T-cell antigen binding, and uses thereof.
Status:
Application
Type:
Utility
Filling date:
8 Apr 2022
Issue date:
11 Aug 2022